Concepedia

Pratapa Prasad

PP

11

Publications

329

Citations

11

H-Index

1997

Active since

Affiliations

Novartis (United States)(Current)

Tris Pharma (United States)

Novartis (Switzerland)

Novartis (France)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Pratapa Prasad is an author at Novartis (United States) specializing in pharmacokinetics, pharmacotherapy, and medicine.

Top concepts

MedicinePharmacologyPharmacotherapyPharmacokineticsNephrologyDiabetesDermatologyHypertensionEndocrinologyAnesthesiology

Publications per year

1997–2011

11

Publications

11

Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers

Gopal Krishna, Lei Ma, Pratapa Prasad et al. · Expert Opinion on Drug Metabolism & Toxicology · 2011 · 45 citations

Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment

Allen Moton, Gopal Krishna, Lei Ma et al. · Current Medical Research and Opinion · 2009 · 42 citations

Safety, Tolerability, and Pharmacokinetics of an Extended-Release Formulation of Fluvastatin Administered Once Daily to Patients with Primary Hypercholesterolemia

Helene D. Sabia, Pratapa Prasad, Harold T. Smith et al. · Journal of Cardiovascular Pharmacology · 2001 · 41 citations

Pharmacokinetics, Pharmacodynamics, and Safety of Microencapsulated Octreotide Acetate in Healthy Subjects

Tianling Chen, Thomas E. Miller, Pratapa Prasad et al. · The Journal of Clinical Pharmacology · 2000 · 38 citations

Pharmaceutical Science, Growth Hormone, Healthy Subjects +10

Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients

Damayanthi Devineni, Yulia H. Walter, Harold T. Smith et al. · The Journal of Clinical Pharmacology · 2003 · 35 citations

Metabolic Syndrome, Hypertension, Renal Function +14

Rows per page

1–5 of 11